Skip to main content
Log in

Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial

  • Originals
  • Published:
Neuroradiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bryan BN, Centeno RS, Hershkowitz N, Poelstra RJ, Osato MS (1982) Neurotoxicity of Iohexol: a new nonionic contrast medium. Radiology 145:379–382

    Google Scholar 

  2. Gebarski SS, Gabrielsen TO, Knake JE, Latack JT, Yang PJ, Hoff JT (1985) Iohexol versus Metizamide for cervical myelography: double-blind trial. AJNR 6:923–926

    Google Scholar 

  3. Latchaw RE, Hirsch Jr. WL, Horton JA, Bissonette D, Shaw DD (1985) Iohexol versus Metrizamide: study of efficacy and morbidity in cervical myelography. AJNR 6:931–933

    Google Scholar 

  4. Lindgren E (1980) Iohexol, a non-ionic contrast medium. Pharmacology and toxicology. Acta Radiol (Suppl) (Stockh) 362: 9–134

    Google Scholar 

  5. Valk J (1982) Lateral cervical, C1–C2, puncture in cervical myelography. Eur Neurol 21:175–180

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valk, J., Crezée, F.C., de Slegte, R.G.M. et al. Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial. Neuroradiology 29, 202–205 (1987). https://doi.org/10.1007/BF00327551

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00327551

Keywords

Navigation